Latest Articles
November 15, 2024
How the Ambry Patient for Life™ Program Minimizes the Need for Provider-Initiated Exome Reanalysis Requests
One of the unique benefits of exome testing is the ability to return to the data from the initial analysis and reevaluate it for new,…
Genetic Testing
Genetic Testing Accuracy
Multigene Panel Testing
Tag
VUS
Whole Exome Sequencing
October 31, 2024
Striking the Perfect Balance in Designing Hereditary Cancer Tests: The Ambry Approach
Ambry’s balanced approach to designing hereditary cancer tests ensures our panels remain relevant and impactful, helping clinicians manage hereditary cancer risk with confidence.
Genetic Testing
Genetic Testing Accuracy
Hereditary Cancer
Multigene Panel Testing
Variant of Unknown Significance
VUS
October 31, 2024
Early Detection in Action: Angie’s CARE Story
One CARE patient’s story demonstrates the power of proactive care and comprehensive high-risk screening.
BRCA1 & 2
Breast Cancer
October 17, 2024
The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment
Pan-cancer panels offer more comprehensive diagnoses, personalized risk assessments, and targeted prevention and treatment strategies.
BRCA1 & 2
Genetic Testing
Genetic Testing Accuracy
Hereditary Cancer
Multigene Panel Testing
Ovarian Cancer
Variant of Unknown Significance
VUS
October 16, 2024
Polyposis Explained: Solving the Mystery with RNA Testing
Genetic counselor Karen Powell shares a case study of her first patient with RNA testing, which helped identify familial adenomatous polyposis (FAP).
Colorectal Cancer
Genetic Testing
RNA
October 10, 2024
Pioneering New Research to Support Rare Disease Patients and Families
Dr. Elizabeth Chao explains how Ambry’s collaboration with PacBio to participate in the GREGoR Consortium to unlock the mysteries of the genome.
Clinical Research
Genetic Testing
Genetic Testing Accuracy
Next Generation Sequencing
Novel Genes
Scientific Research